FEATURED NEWS

• HDA-Supported Pilot Results in Successful Automation of Authorized Trading Partner Credentialing for DSCSA

  March 30, 2021

  The Healthcare Distribution Alliance (HDA), in coordination with the Center for Supply Chain Studies, announced the successful conclusion of an industry-wide pilot of an interoperable “authorized trading partner” credentialing ecosystem to support the requirements of the federal traceability law, the Drug Supply Chain Security Act (DSCSA).

• ‘Health Delivered’ Campaign Spotlights Integral Role of Distributors in Response To COVID-19 and Beyond

  March 22, 2021

  The Healthcare Distribution Alliance (HDA) today launched a campaign — “Health Delivered” — to communicate the healthcare distribution industry’s integral role and logistics expertise during the COVID-19 response, as well as distributors’ ongoing responsibility to fulfill the daily healthcare needs of all Americans. The first component of the campaign is a television ad showcasing HDA member company personnel working tirelessly in the face of a global pandemic to make sure American hospitals, pharmacies, providers and patients have the critical medicines and supplies they require.

• HDA Statement on Confirmation of Xavier Becerra as HHS Secretary

  March 18, 2021

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement.

• HDA Statement on Enactment of The American Rescue Plan

  March 11, 2021

  HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to today’s enactment of The American Rescue Plan Act of 2021 by President Biden.

• HDA Statement on FDA Authorization of Johnson & Johnson COVID-19 Vaccine

  February 27, 2021

  HDA President and CEO Chester “Chip” Davis, Jr., released a statement regarding the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization (EUA) for the Johnson & Johnson (Janssen Biotech) COVID-19 vaccine candidate.